Blood and Blood Product MEDVAMC   2

Background
This solicitation is for Blood & Blood products in support of MEDVAMC. It is an unrestricted request for proposal (RFP) for a fixed price Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract is subject to Federal Acquisition Regulation 15 and 16.504.

Work Details
The Statement of Work (SOW) outlines the specific products and services required, including blood and blood products such as Adsorption, Cell Separation, CMV Antibody negative component, Cryoprecipitate AHF, Single, Donath-Landsteiner Test, Elution, Neutralization, Panel, Leukocyte Red Blood Cell-Irradated, Leukoreduced Red Blood Cell-Irradated, CMV negative, Packed Human Red Blood Cells Deglycerolized, Patient Antigen Typing, Plasma Fresh Frozen, Plasma Frozen within 24 hours, Plasma, Apheresis, Plasma, Cryoprecipitate Reduced, Platelets, Pretreatment of Patient's RBC for Testing (Enzyme Treatment), Pretreatment of Patient's Serum for Testing, Red Blood Cell O neg. (surcharge), Red Blood Cells Leukoreduced (10-20% O neg. required), Red Blood Cells, Frozen, Red Blood Cells, Washed and Whole Blood, Leuko-Reduced.
The period of performance is five 12-month ordering periods from February 1st, 2023 to January 31st, 2028.

Period of Performance
The period of performance is five 12-month ordering periods from February 1st, 2023 to January 31st, 2028.

Place of Performance
The products are to be delivered to the Department of Veterans Affairs Medical Center in Houston TX.